176 related articles for article (PubMed ID: 25405480)
1. Assessment of CD4+ T cell responses to glutamic acid decarboxylase 65 using DQ8 tetramers reveals a pathogenic role of GAD65 121-140 and GAD65 250-266 in T1D development.
Chow IT; Yang J; Gates TJ; James EA; Mai DT; Greenbaum C; Kwok WW
PLoS One; 2014; 9(11):e112882. PubMed ID: 25405480
[TBL] [Abstract][Full Text] [Related]
2. Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA(null) NOD mice.
Liu J; Purdy LE; Rabinovitch S; Jevnikar AM; Elliott JF
Diabetes; 1999 Mar; 48(3):469-77. PubMed ID: 10078545
[TBL] [Abstract][Full Text] [Related]
3. Glutamic acid decarboxylase T lymphocyte responses associated with susceptibility or resistance to type I diabetes: analysis in disease discordant human twins, non-obese diabetic mice and HLA-DQ transgenic mice.
Boyton RJ; Lohmann T; Londei M; Kalbacher H; Halder T; Frater AJ; Douek DC; Leslie DG; Flavell RA; Altmann DM
Int Immunol; 1998 Dec; 10(12):1765-76. PubMed ID: 9885897
[TBL] [Abstract][Full Text] [Related]
4. Proinsulin-specific, HLA-DQ8, and HLA-DQ8-transdimer-restricted CD4+ T cells infiltrate islets in type 1 diabetes.
Pathiraja V; Kuehlich JP; Campbell PD; Krishnamurthy B; Loudovaris T; Coates PT; Brodnicki TC; O'Connell PJ; Kedzierska K; Rodda C; Bergman P; Hill E; Purcell AW; Dudek NL; Thomas HE; Kay TW; Mannering SI
Diabetes; 2015 Jan; 64(1):172-82. PubMed ID: 25157096
[TBL] [Abstract][Full Text] [Related]
5. Induction of insulitis by glutamic acid decarboxylase peptide-specific and HLA-DQ8-restricted CD4(+) T cells from human DQ transgenic mice.
Wen L; Wong FS; Burkly L; Altieri M; Mamalaki C; Kioussis D; Flavell RA; Sherwin RS
J Clin Invest; 1998 Sep; 102(5):947-57. PubMed ID: 9727063
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of GAD65-specific CD4+ T cells in healthy and type 1 diabetic subjects.
Danke NA; Yang J; Greenbaum C; Kwok WW
J Autoimmun; 2005 Dec; 25(4):303-11. PubMed ID: 16249070
[TBL] [Abstract][Full Text] [Related]
7. Discovery of a Selective Islet Peptidome Presented by the Highest-Risk HLA-DQ8trans Molecule.
van Lummel M; van Veelen PA; de Ru AH; Pool J; Nikolic T; Laban S; Joosten A; Drijfhout JW; Gómez-Touriño I; Arif S; Aanstoot HJ; Peakman M; Roep BO
Diabetes; 2016 Mar; 65(3):732-41. PubMed ID: 26718497
[TBL] [Abstract][Full Text] [Related]
8. Determination of glutamic acid decarboxylase 65 peptides presented by the type I diabetes-associated HLA-DQ8 class II molecule identifies an immunogenic peptide motif.
Herman AE; Tisch RM; Patel SD; Parry SL; Olson J; Noble JA; Cope AP; Cox B; Congia M; McDevitt2 HO
J Immunol; 1999 Dec; 163(11):6275-82. PubMed ID: 10570321
[TBL] [Abstract][Full Text] [Related]
9. Modulatory role of DR4- to DQ8-restricted CD4 T-cell responses and type 1 diabetes susceptibility.
Ge X; Piganelli JD; Tse HM; Bertera S; Mathews CE; Trucco M; Wen L; Rudert WA
Diabetes; 2006 Dec; 55(12):3455-62. PubMed ID: 17130492
[TBL] [Abstract][Full Text] [Related]
10. GAD65- and proinsulin-specific CD4+ T-cells detected by MHC class II tetramers in peripheral blood of type 1 diabetes patients and at-risk subjects.
Oling V; Marttila J; Ilonen J; Kwok WW; Nepom G; Knip M; Simell O; Reijonen H
J Autoimmun; 2005 Nov; 25(3):235-43. PubMed ID: 16263242
[TBL] [Abstract][Full Text] [Related]
11. Characterization of self-glutamic acid decarboxylase 65-reactive CD4+ T-cell clones established from Japanese patients with insulin-dependent diabetes mellitus.
Tabata H; Kanai T; Yoshizumi H; Nishiyama S; Fujimoto S; Matsuda I; Yasukawa M; Matsushita S; Nishimura Y
Hum Immunol; 1998 Sep; 59(9):549-60. PubMed ID: 9757911
[TBL] [Abstract][Full Text] [Related]
12. Differences in self-peptide binding between T1D-related susceptible and protective DR4 subtypes.
Ge X; James EA; Reijonen H; Kwok WW
J Autoimmun; 2011 Mar; 36(2):155-60. PubMed ID: 21257290
[TBL] [Abstract][Full Text] [Related]
13. CD4+ and CD8+ T-cell clones from congenital rubella syndrome patients with IDDM recognize overlapping GAD65 protein epitopes. Implications for HLA class I and II allelic linkage to disease susceptibility.
Ou D; Jonsen LA; Metzger DL; Tingle AJ
Hum Immunol; 1999 Aug; 60(8):652-64. PubMed ID: 10439311
[TBL] [Abstract][Full Text] [Related]
14. Emergence of a broad repertoire of GAD65-specific T-cells in type 1 diabetes patients with graft dysfunction after allogeneic islet transplantation.
Chujo D; Foucat E; Takita M; Itoh T; Sugimoto K; Shimoda M; Yagi K; Yamagishi M; Tamura Y; Yu L; Naziruddin B; Levy MF; Ueno H; Matsumoto S
Cell Transplant; 2012; 21(12):2783-95. PubMed ID: 22963904
[TBL] [Abstract][Full Text] [Related]
15. Autoantigen-specific memory CD4+ T cells are prevalent early in progression to Type 1 diabetes.
Oling V; Reijonen H; Simell O; Knip M; Ilonen J
Cell Immunol; 2012; 273(2):133-9. PubMed ID: 22270037
[TBL] [Abstract][Full Text] [Related]
16. HLA-DR3 mediated CD4 T cell response against GAD65 in type 1 diabetes patients.
Chuzho N; Mishra N; Tandon N; Kanga U; Mishra G; Sharma A; Mehra NK; Kumar N
J Diabetes; 2023 Jul; 15(7):607-621. PubMed ID: 37309552
[TBL] [Abstract][Full Text] [Related]
17. A low antigen dose selectively promotes expansion of high-avidity autoreactive T cells with distinct phenotypic characteristics: a study of human autoreactive CD4+T cells specific for GAD65.
Oling V; Geubtner K; Ilonen J; Reijonen H
Autoimmunity; 2010 Dec; 43(8):573-82. PubMed ID: 20370569
[TBL] [Abstract][Full Text] [Related]
18. The regulatory role of DR4 in a spontaneous diabetes DQ8 transgenic model.
Wen L; Chen NY; Tang J; Sherwin R; Wong FS
J Clin Invest; 2001 Apr; 107(7):871-80. PubMed ID: 11285306
[TBL] [Abstract][Full Text] [Related]
19. Distinct Phenotypes of Islet Antigen-Specific CD4+ T Cells Among the 3 Subtypes of Type 1 Diabetes.
Chujo D; Kawabe A; Matsushita M; Takahashi N; Tsutsumi C; Haseda F; Imagawa A; Hanafusa T; Ueki K; Kajio H; Yagi K; Tobe K; Shimoda M
J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32652026
[TBL] [Abstract][Full Text] [Related]
20. Detection of GAD65 autoreactive T-cells by HLA class I tetramers in type 1 diabetic patients.
Giuliani L; Mele R; Di Giovine M; Altieri L; Crinò A; Ravà L; Fierabracci A
J Biomed Biotechnol; 2009; 2009():576219. PubMed ID: 20029631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
